Preclinical and first-in-human safety studies on a novel magnetism-based haemofiltration method.

Extracorporeal haemofiltration devices that selectively remove cytokines could represent an adjunctive treatment in inflammatory diseases. One such device is the "IL-6-Sieve", wherein magnetic Anti-IL-6 Beads are introduced into an extracorporeal circuit via a Bead Adapter and then removed along with any surface-bound interleukin (IL)-6 by a Filter deployed in a Magnet, before the blood is returned to the patient. We report here on a series of animal studies, and a first-in-human study, on the safety of the IL-6-Sieve.

Assessing the parameters modulating optical losses of iron oxide nanoparticles under near infrared irradiation.

Heating mediated by iron oxide nanoparticles subjected to near infrared irradiation has recently gained lots of interest. The high optical loss values reported in combination with the optical technologies already existing in current clinical practices, have made optical heating mediated by iron oxide nanoparticles an attractive choice for treating internal or skin tumors. However, the identification of the relevant parameters and the influence of methodologies for quantifying the optical losses released by iron oxide nanoparticles are not fully clear.

Unveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applications.

Iron oxide nanoparticles (IONPs) are well-known contrast agents for MRI for a wide range of sizes and shapes. Their use as theranostic agents requires a better understanding of their magnetic hyperthermia properties and also the design of a biocompatible coating ensuring their stealth and a good biodistribution to allow targeting of specific diseases. Here, biocompatible IONPs of two different shapes (spherical and octopod) were designed and tested and to evaluate their abilities as high-end theranostic agents.

Unravelling the Thermal Decomposition Parameters for The Synthesis of Anisotropic Iron Oxide Nanoparticles.

Iron oxide nanoparticles are widely used as a contrast agent in magnetic resonance imaging (MRI), and may be used as therapeutic agent for magnetic hyperthermia if they display in particular high magnetic anisotropy. Considering the effect of nanoparticles shape on anisotropy, a reproducible shape control of nanoparticles is a current synthesis challenge. By investigating reaction parameters, such as the iron precursor structure, its water content, but also the amount of the surfactant (sodium oleate) reported to control the shape, iron oxide nanoparticles with different shape and composition were obtained, in particular, iron oxide nanoplates.

Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia.

Iron oxide nanoparticles are widely used for biological applications thanks to their outstanding balance between magnetic properties, surface-to-volume ratio suitable for efficient functionalization and proven biocompatibility. Their development for MRI or magnetic particle hyperthermia concentrates much of the attention as these nanomaterials are already used within the health system as contrast agents and heating mediators. As such, the constant improvement and development for better and more reliable materials is of key importance.

Real-time tracking of delayed-onset cellular apoptosis induced by intracellular magnetic hyperthermia.

Aim: To assess cell death pathways in response to magnetic hyperthermia.

Materials & Methods: Human melanoma cells were loaded with citric acid-coated iron-oxide nanoparticles, and subjected to a time-varying magnetic field. Pathways were monitored in vitro in suspensions and in situ in monolayers using fluorophores to report on early-stage apoptosis and late-stage apoptosis and/or necrosis.

Protein A-conjugated iron oxide nanoparticles for separation of Vibrio cholerae from water samples.

Pathogen separation is of great significance for precise detection and prevention of disease outbreaks. For the first time, protein A conjugated with chitosan-coated iron oxide nanoparticles was prepared for pathogen separation at low concentrations from liquid samples. Vibrio cholerae O1 (VO1) bacteria were used for testing the effectiveness of this conjugate.

A low cost synthesis method for functionalised iron oxide nanoparticles for magnetic hyperthermia from readily available materials.

The synthesis of iron oxide nanocrystals from reagents taken from high street sources using thermal decomposition of an iron-fatty acid precursor in a high boiling point solvent in the presence of surfactants is presented. The nanocrystals were characterised using a variety of techniques including: electron microscopy, X-ray dispersive spectroscopy, infrared spectroscopy, X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS) and magnetometry. Thermogravimetric analysis (TGA) is also used to compare the decomposition behaviour of iron oleate and iron palmitate, our nanoparticle precursors.

Magnetic nanoparticles for in vivo use: a critical assessment of their composition.

Three different magnetic samples with particle sizes ranging from 10 to 30 nm were prepared by wet chemical methods. The powders were heated at 100, 150, 200, and 250 °C during 30 min under air. Ferrous and total iron contents were determined immediately after the synthesis and after the thermal treatments.

Multilayered nanocoatings incorporating superparamagnetic nanoparticles for tracking of pancreatic islet transplants with magnetic resonance imaging.

A novel strategy for delivering functionalised superparamagnetic iron oxide nanoparticles to the outer surface of pancreatic islet grafts, using chemically modified polymeric nanolayers, has been developed for tracking of engrafted pancreatic islets by magnetic resonance imaging.